Skip to main content
. 2010 Apr 8;87(3):1045–1055. doi: 10.1007/s00253-010-2522-6

Table 2.

Oligonucleotides used in this study

Primer name Sequence 5′→3′
K21 GGCGAAGCTTGTGGCATCCTTGGACACCTTG
K22 CTTGATGGTTTCGTCCGAATGGC
K23 CATTCGGACGAAACCATCAAGGGCTAAATCAACCGGTTTTAAGACCC
K24 GGGAATTCTTCCGTGGCAACTCGACCTG
K673 GCACAATTGCGTCAAAGGGGTGAAACTTAAGCAATTC
K674 GATTTTGGCAAAATGGTGGAAGGGCGGATCCTGCTAGCAGCCACTA
K675 GGATCCTGCTAGCAGCCACTAGTTAGCTCTAGAAATAGCATGCCAGCAGATCTAA
K676 AAGCCTGCAGGTCGACAAGCGGCCGCAATCCTAGGTTTAGATCTGCTGGCATGCTATTT
K709 GGGTCGACATGGAGAAAAAAATCACTGGATATACCACC
K710 GGCGGCGGCCGCTTACGCCCCGCCCTGCCACT
K717 AACTGCAGGGTGACGTGAACTCCCGCCG
K718 GGGTCGACTGTATGTCCTCCTGGACTTCGTGG
K753 GGCCGCTCGAGATGTTGACAAAAGCAACAAAAGAACAAAAAT
A124 ACGCAGTCGACCTAGAGAGCTTTCGTTTTCATGAGT
K764 GGCCGCTCGAGATTAAAGAGGAGAAAGGTAATGGCTATTGAACTGCTTTATGATGCTG
K765 CATTACCTTTCTCCTCTTTAATTTAAGCGGTTTCTGCGCGAGC
K766 ATTAAAGAGGAGAAAGGTAATGATCCCACTTCGTTCAAAAGTCAC
K767 GGCGGCGGCCGCTTAGTCGACCTGACGGACTGCACC
K852 GGCGGCGGCCGCAAAGAGGAGAAAGGTACCATGTATACAGTAGGAG
K853 GGACTAGTTTATGATTTATTTTGTTCAGCAAATAGTTTGC
K887 GGACTAGTGAAGTCCAGGAGGGCTGCAATGACCACTGCTGCACCCCAAG
K888 GGACTAGTTTAGAAACGAATCGCCACACGACC
K950 GGCGAAGCTTCCTACGAAGAAGGCGGAGAAACT
K951 GCGCGGTTTTCTTCCTTGAAAAGT
K952 ACTTTTCAAGGAAGAAAACCGCGCGGCAAATGACCTCGCTCCGG
K953 GGGAATTCGACGCGGAAAATACTCCCTAACAGC
K960 GGCGAAGCTTATGGCCGATCAAGCAAAACTTGG
K961 CCATGAATGCACGTGCGTACAT
K962 GTACGCACGTGCATTCATGGATCGCACACCTGGTTCACCG
K963 GCACAATTGTTATTCCTCAGGAGCGTTTGGATCT
K972 GGCGAAGCTTATGACTGATTTTTTACGCGATGACATCAG
K973 CTCCGCAGACTGCAAAGCGT
K974 ACGCTTTGCAGTCTGCGGAGGGGTGCTCAGCTGGTCACAG
K975 GGGAATTCCTAGCCGGAGTTGCGCAGC
K976 GGCGAAGCTTGTGTCGACTCACACATCTTCAACG
K977 CTTCACAAAGATGGGGTAAGTCTGGC
K978 ACTTACCCCATCTTTGTGAAGCGCTTCGGCAACACCTCTG
K979 GCACAATTGTTAGGAAACGACGACGATCAAGTCG

Underlined nucleotides indicate restriction sites